Sherfesee L - Search Results

1

Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial.

Orlov MV, Ghali JK, Araghi-Niknam M, Sherfesee L, Sahr D, Hettrick DA; Atrial High Rate Trial Investigators. Orlov MV, et al. Among authors: sherfesee l. Pacing Clin Electrophysiol. 2007 Mar;30(3):404-11. doi: 10.1111/j.1540-8159.2007.00682.x. Pacing Clin Electrophysiol. 2007. PMID: 17367361 Clinical Trial.

2

The influence of symptoms and device detected atrial tachyarrhythmias on medical management: insights from A-HIRATE.

Ghali JK, Orlov MV, Araghi-Niknam M, Sherfesee L, Hettrick DA. Ghali JK, et al. Among authors: sherfesee l. Pacing Clin Electrophysiol. 2007 Jul;30(7):850-7. doi: 10.1111/j.1540-8159.2007.00772.x. Pacing Clin Electrophysiol. 2007. PMID: 17584266

3

The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.

Sweeney MO, Ellenbogen KA, Miller EH, Sherfesee L, Sheldon T, Whellan D. Sweeney MO, et al. Among authors: sherfesee l. J Cardiovasc Electrophysiol. 2006 Dec;17(12):1295-8. doi: 10.1111/j.1540-8167.2006.00656.x. Epub 2006 Nov 1. J Cardiovasc Electrophysiol. 2006. PMID: 17081208

4

Remote monitoring of implantable cardioverter defibrillators: a prospective analysis.

Schoenfeld MH, Compton SJ, Mead RH, Weiss DN, Sherfesee L, Englund J, Mongeon LR. Schoenfeld MH, et al. Among authors: sherfesee l. Pacing Clin Electrophysiol. 2004 Jun;27(6 Pt 1):757-63. doi: 10.1111/j.1540-8159.2004.00524.x. Pacing Clin Electrophysiol. 2004. PMID: 15189530

5

Atrial pacing or ventricular backup-only pacing in implantable cardioverter-defibrillator patients.

Sweeney MO, Ellenbogen KA, Tang AS, Whellan D, Mortensen PT, Giraldi F, Sandler DA, Sherfesee L, Sheldon T; Managed Ventricular Pacing Versus VVI 40 Pacing Trial Investigators. Sweeney MO, et al. Among authors: sherfesee l. Heart Rhythm. 2010 Nov;7(11):1552-60. doi: 10.1016/j.hrthm.2010.05.038. Epub 2010 Jun 4. Heart Rhythm. 2010. PMID: 20685401 Clinical Trial.

6

Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients.

Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Sweeney MO, et al. Among authors: sherfesee l. Heart Rhythm. 2010 Mar;7(3):353-60. doi: 10.1016/j.hrthm.2009.11.027. Epub 2009 Dec 2. Heart Rhythm. 2010. PMID: 20185109

7

Diurnal, Seasonal, and Monthly Variations in Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators.

Maan A, Sherfesee L, Lexcen D, Heist EK, Cheng A. Maan A, et al. Among authors: sherfesee l. JACC Clin Electrophysiol. 2019 Aug;5(8):979-986. doi: 10.1016/j.jacep.2019.05.014. Epub 2019 Jul 31. JACC Clin Electrophysiol. 2019. PMID: 31439301 Free article.

8

Rhythm monitoring strategies in patients at high risk for atrial fibrillation and stroke: A comparative analysis from the REVEAL AF study.

Reiffel JA, Verma A, Kowey PR, Halperin JL, Gersh BJ, Elkind MSV, Ziegler PD, Kaplon RE, Sherfesee L, Wachter R; REVEAL AF Investigators. Reiffel JA, et al. Among authors: sherfesee l. Am Heart J. 2020 Jan;219:128-136. doi: 10.1016/j.ahj.2019.07.016. Am Heart J. 2020. PMID: 31862084

9

Rationale and design of REVEAL AF: a prospective study of previously undiagnosed atrial fibrillation as documented by an insertable cardiac monitor in high-risk patients.

Reiffel J, Verma A, Halperin JL, Gersh B, Tombul S, Carrithers J, Sherfesee L, Kowey P. Reiffel J, et al. Among authors: sherfesee l. Am Heart J. 2014 Jan;167(1):22-7. doi: 10.1016/j.ahj.2013.10.007. Epub 2013 Oct 23. Am Heart J. 2014. PMID: 24332138

10

Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score.

Ahmed FZ, Blomström-Lundqvist C, Bloom H, Cooper C, Ellis C, Goette A, Greenspon AJ, Love CJ, Johansen JB, Philippon F, Tarakji KG, Holbrook R, Sherfesee L, Xia Y, Seshadri S, Lexcen DR, Krahn AD. Ahmed FZ, et al. Among authors: sherfesee l. Europace. 2021 Sep 8;23(9):1446-1455. doi: 10.1093/europace/euab028. Europace. 2021. PMID: 33755136 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters